The NeuroNEXT Gene Therapy Consortium: Designing and Advising on Quality Gene Therapy Trials in Rare and Ultra-rare Neurological Disorders
Saved in:
| Main Authors: | David Klements, MS, Marianne Chase, Hyun Joo (Sophie) Cho, Aleksander Videnovic, Christopher Coffey, Ph.D., Dixie Ecklund, R.N., M.S.N., M.B.A., Merit Cudkowicz, M.D., M.Sc. |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Neurotherapeutics |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1878747925001230 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
When is preservative-free therapy of glaucoma needed and advisable?
by: T. N. Malishevskaya, et al.
Published: (2021-09-01) -
In vivo applications and toxicities of AAV-based gene therapies in rare diseases
by: Qian Zhao, et al.
Published: (2025-07-01) -
Progress in advanced cellular and gene therapies in South Africa and barriers to patient access: A National Consortium paper on behalf of the BloodSA Cell and Gene Therapy working party
by: C Hendricks, et al.
Published: (2025-06-01) -
Accelerating ALS Drug Development: The HEALEY ALS Platform Trial's Adaptive Design and Efficient Integration of Investigational Products
by: Brittney Harkey, Ph.D., et al.
Published: (2025-07-01) -
Increased burden of rare variants in GWAS associated genes in familial multiple sclerosis
by: Aleksander Turk, et al.
Published: (2025-07-01)